跳至主要内容
临床试验/NCT05557344
NCT05557344招募中4 期

Oral Versus Intravenous Acetaminophen for the Treatment of Pain Secondary to Long Bone Fracture Requiring Surgery in Children

Dr. Niina Kleiber1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年4月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Change in pain scores

研究概览

简要总结

Intravenous (IV) acetaminophen entered the Canadian market recently and children with acute pain following a trauma are ideal candidates for the IV formulation as it may improve analgesia and consequently decrease the amount of opioids needed to achieve pain control. Due to the limited data on bioavailability, adverse effect profile and efficacy of IV versus oral acetaminophen, it is of paramount importance to generate evidence-based data to guide clinicians with a rational choice of route of administration of acetaminophen.

Therefore, we propose a pilot study to inform a future large randomized controlled trial (RCT) to compare pharmacokinetics, feasibility, preliminary effects and side effects profile of oral versus IV acetaminophen in children admitted for surgical fixation of a long-bone fracture.

详细描述

Patients admitted for a long-bone fracture needing surgical fixation are generally initially treated with intranasal and/or IV opioids in association to oral acetaminophen and ibuprofen. Following surgery they are treated with a combination of morphine and acetaminophen. To address the issue of opioid epidemics, the Pediatric Orthopaedic Society of North America recommends reduction of their prescription as much as possible by promoting, among others, use of multimodal analgesia after surgery. The current proposal aims to improve post-operative pain control in children following a surgical fixation of a long-bone fracture and decrease the use of opioids through better co-analgesia. As such, this study aims to assess the pharmacokinetics (PK) and the efficacy of oral versus IV formulations of acetaminophen after surgery for long bone fractures in children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Likely to undergo surgery for a long-bone fracture
  • Aged between 2-18 years (IV acetaminophen is approved for children ≥2 years)
  • IV line per standard of care

排除标准

  • Contraindication to oral drug administration
  • Patients unable to take oral solution
  • Known hypersensitivity or allergy to acetaminophen or any of the excipients in the IV or oral formulation
  • Use of any medication known to interact with acetaminophen including, but not restricted to phenytoin and carbamazepine (1)
  • Pregnancy
  • Known Hepatic insufficiency or hepatic disease
  • Known or diagnosed severe renal failure
  • Multiple trauma (more than two long bone fractures)
  • Hemodynamic or respiratory compromise
  • Altered level of consciousness (Glasgow coma scale <15)

研究组 & 干预措施

Oral acetaminophen arm

Active Comparator

they will receive oral acetaminophen, placebo (saline) IV

干预措施: Acetaminophen (Drug)

IV acetaminophen arm

Active Comparator

they will receive IV acetaminophen, placebo oral

干预措施: Acetaminophen IV (Drug)

结局指标

主要结局

Change in pain scores

时间窗: During 24h (starting with the first dose of study drug)

Pain scores within the first 24 hours following initiation of study drug, using the scales Face, Legs, Activity, Cry, Consolability (FLACC, 0-2 per item for a total of 10, 10 being the worst pain) and verbal numerical rating (VNR, 0-10, 10 being the worst pain).

Difference in quantity of rescue opioids

时间窗: During 24h (starting with the first dose of study drug)

Quantity of rescue opioids (morphine equivalent in mg/kg) within the first 24 hours following initiation of study drug

次要结局

  • Adverse events(During 24h (starting with the first dose of study drug))
  • Determination of oral bioavailability(During 24 hours after the first dose of study drug)

研究者

发起方
Dr. Niina Kleiber
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Niina Kleiber

Paediatrician and Clinical Pharmacologist

St. Justine's Hospital

研究点 (1)

Loading locations...

相似试验